Immunometabolic Reprogramming in Response to HIV Infection Is Not Fully Normalized by Suppressive Antiretroviral Therapy.
Immunometabolic Reprogramming in Response to HIV Infection Is Not Fully Normalized by Suppressive Antiretroviral Therapy.
复制标题
响应HIV感染的免疫代谢重编程未通过抑制性抗逆转录病毒疗法完全归一化。
DOI:
10.3390/v14061313
复制
发表时间:
2022-06-15
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Background: HIV infection results in immunometabolic reprogramming. While we are beginning to understand how this metabolic reprogramming regulates the immune response to HIV infection, we do not currently understand the impact of ART on immunometabolism in people with HIV (PWH). Methods: Serum obtained from HIV-infected (n = 278) and geographically matched HIV seronegative control subjects (n = 300) from Rakai Uganda were used in this study. Serum was obtained before and ~2 years following the initiation of ART from HIV-infected individuals. We conducted metabolomics profiling of the serum and focused our analysis on metabolic substrates and pathways assocaited with immunometabolism. Results: HIV infection was associated with metabolic adaptations that implicated hyperactive glycolysis, enhanced formation of lactate, increased activity of the pentose phosphate pathway (PPP), decreased β-oxidation of long-chain fatty acids, increased utilization of medium-chain fatty acids, and enhanced amino acid catabolism. Following ART, serum levels of ketone bodies, carnitine, and amino acid metabolism were normalized, however glycolysis, PPP, lactate production, and β-oxidation of long-chain fatty acids remained abnormal. Conclusion: Our findings suggest that HIV infection is associated with an increased immunometabolic demand that is satisfied through the utilization of alternative energetic substrates, including fatty acids and amino acids. ART alone was insufficient to completely restore this metabolic reprogramming to HIV infection, suggesting that a sustained impairment of immunometabolism may contribute to chronic immune activation and comorbid conditions in virally suppressed PWH.
登录
查看更多内容
影响因子:
1
作者:
Datta PK;Kaminski R;Hu W;Pirrone V;Sullivan NT;Nonnemacher MR;Dampier W;Wigdahl B;Khalili K
通讯作者:
Khalili K
DOI:
10.1161/circheartfailure.113.000521
发表时间:
2013-09-01
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Djoussé L;Benkeser D;Arnold A;Kizer JR;Zieman SJ;Lemaitre RN;Tracy RP;Gottdiener JS;Mozaffarian D;Siscovick DS;Mukamal KJ;Ix JH
通讯作者:
Ix JH
影响因子:
1.5
作者:
Hegedus A;Kavanagh Williamson M;Khan MB;Dias Zeidler J;Da Poian AT;El-Bacha T;Struys EA;Huthoff H
通讯作者:
Huthoff H
影响因子:
6.4
作者:
Cassol, Edana;Malfeld, Susan;Rossouw, Theresa
通讯作者:
Rossouw, Theresa
影响因子:
3.7
作者:
Barrero CA;Datta PK;Sen S;Deshmane S;Amini S;Khalili K;Merali S
通讯作者:
Merali S